MRES Financials
Institute of Biomedical Research Corp - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$9.47M
EPS
$-1.59
Income Statement Highlights
Most Recent Quarter: 2025-03-31
Revenue
$49487.00
Gross Profit
$21402.00
Operating Income
$-756513.00
Net Income
$-632720.00
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$3.31M
Total Liabilities
$775716.00
Shareholders Equity
$583870.00
Cash & Equivalents
$11804.00
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$2.06M
CapEx
$0
Free Cash Flow
$2.06M
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MRES revenue?
MRES's most recent quarterly revenue was $49487.00. Annual revenue can be calculated by summing the four most recent quarters.
Is MRES profitable?
MRES reported a loss of $632,720 in the most recent quarter.
What is MRES market cap?
MRES has a market capitalization of $9.47M, making it a small-cap stock.
Does MRES have debt?
View MRES's balance sheet for debt information.
What is MRES cash flow?
MRES's most recent quarterly free cash flow was $2.06M.